header image

Join Us

“Treatment Advances: The Latest in
Pancreatic Cancer Clinical Research”

This webinar was recorded on World Pancreatic Cancer Day, November 19, 2020

WATCH NOW

PanCAN President and CEO Julie Fleshman, JD, MBA, moderates the event featuring a panel of renowned pancreatic cancer research experts.

The discussion includes: The importance of genetic and biomarker testing through PanCAN’s Know Your Tumor® service and how it helps determine the best treatment options; current treatment approaches, including targeted therapy and immunotherapy; PanCAN’s Precision PromiseSM, our groundbreaking clinical trial now enrolling eligible patients; and what lies ahead in the research field.

Featuring

card image

Julie M. Fleshman, JD, MBA,

PanCAN President and CEO, leading the way for more than two decades in PanCAN’s approach to take bold steps to make progress in pancreatic cancer research and improve patient outcomes

card image

Lynn Matrisian, PhD, MBA,

PanCAN Chief Science Officer, has dedicated nearly nine years to developing PanCAN’s scientific initiatives including our Know Your Tumor precision medicine service, Precision Promise and our upcoming Early Detection Initiative

card image

Andrew Hendifar, MD, MPH

Medical Director of Pancreatic Cancer at Cedars-Sinai Medical Center, PanCAN Precision Promise Steering Committee member and site Principal Investigator

card image

Thomas George, MD, FACP

Director of the GI Oncology Program at the University of Florida Health Cancer Center, PanCAN Precision Promise site Principal Investigator

Contact our PanCAN’s Patient Services team

for answers to any questions you have about treatment options, including clinical trials, that may be right for you. Our expert case managers are here from 7 a.m. to 5 p.m. PT, Monday through Friday, to help.
Contact us at 1-877-272-6226 or patientcentral@pancan.org.

Thank you to our sponsors

logo image
logo image

Thank you to our Scientific & Medical Affairs Industry Members

sponsor logo block